Pay in 4 interest-free payments of $6.03 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
The three populations with current access
Eligible participants were adults without diabetes with a BMI of at least 30 kg/m, or at least 27 kg/m with hypertension or dyslipidaemia
Similar to what was observed for the SGLT2i cohort, new users of GLP-1 RA in the later periods had a longer minimum recorded duration of CKD (mean: 4.6 years vs
.png)
AOD 9604 regulatory status AOD 9604 is not FDA-approved for any medical indication
US$ 28.58
US$ 25.03
US$ 28.96
